Adjuvant VEGF Blockers Disappoint in Kidney Cancer

(MedPage Today) -- Survival no better with post-surgical sunitinib or sorafenib than with placebo. via MedPageToday.com - medical news plus CME for physicians Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://ift.tt/1EYIcrP